HLBank Research Highlights

Rubber Products - 2015 Outlook

HLInvest
Publish date: Wed, 14 Jan 2015, 09:46 AM
HLInvest
0 12,263
This blog publishes research reports from Hong Leong Investment Bank

Highlights / Comments

  • 2014: Glove stocks were rather defensive (average return of -4.2% vs. FBM100 Index of -6.2%). Karex, on the other hand, has performed very well, with gain of 22.6%.
  • Raw materials: Latex prices have been on a downtrend. However, with efforts to tackle global glut seen from several parties, we expect rubber prices to remain rangebound.
  • Fuel: We expect moderate annual increase in electricity cost and biannual price adjustments in natural gas, in line with Government’s subsidy rationalisation plan.
  • Labour: Being in a labour intensive industry, labour costs make up 13% of total cost. Hence, most expansion blueprint is focusing on automation to reduce headcounts .
  • Forex: Expect MYR to remain weak around RM3. 50/US$. Neutral for glove players due to forex savings pass -through, positive for Karex as it enjoys the USD appreciation benefits.
  • Disease outbreak: The deadly Ebola outbreak in western Africa is not expected to be a catalyst as yet.
  • Global demand: Glove demand will remain resilient with expected growth of 6% -8% in 2015. Condom demand will grow strongly at 6-year projected CAGR of 9.0%.
  • In general, both sub-sectors are experiencing resilient growth. However, the fact that glove industry has to pass on cost savings leads us to prefer condom player, Karex.
  • Rubber glove : Low rubber prices, strengthening USD and resilient global glove demand will contribute favourably. Nevertheless, it will be neutralised by unfavourable factors , such as rising fuel costs and wages, as well as the yet -toreach equilibrium between demand and supply of rubber glove. Not forgetting also the industry practice, whereby any cost savings have to be passed on.
  • Condom: We continue to be positive in Karex given its favourable outlook from both macro (export -oriented, USDdenominated, robust global demand growth, low condom usage rate) and micro (well-planned capacity expansion, acquisition of ONE ® brand, strong in-house R&D) factors.

Catalysts

  • Surge in demand in the event of a disease outbreak ; more stringent requirements and increased spending in the healthcare sector; appreciation of USD against MYR and lower rubber prices to boost profitability.

Risks

  • Mismatch between demand and supply in rubber glove; potential increase in natural and/or synthetic latex prices; depreciation of USD against MYR.

Forecasts

  • Unchanged.

Rating

NEUTRAL

Positives

  • Softening of natural and/or synthetic latex prices ,continuous improvement in cost efficiency .

Negatives

  • Weakening of USD against MYR.

Valuation

Maintain NEUTRAL on the sector with the following ratings:

  • Hartalega (HOLD, TP: RM7.43, 16.2x CY16 EPS pegged to 1SD above 5-year historical average P/E).
  • Kossan (HOLD, TP: RM4.49, 12.8x CY16 EPS pegged to 1SD above 5-year historical average P/E).
  • Top Glove (HOLD, TP: RM4.62, 13.5x CY16 EPS pegged to 1SD below 3-year historical average P/E).
  • Karex (BUY, TP: RM4.00 as we roll forward valuation, 19x CY16 EPS pegged to average P/E of international peers).

Source: Hong Leong Investment Bank Research - 14 Jan 2015

Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment